Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sinzinger

Showing results (221-230 of 672) with videos related to

Pageof 68
Sort By:
Angiology|February 1, 1986
Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular diseaseH Sinzinger, P Fitscha, B A Peskar
Prostaglandins & Other Lipid Mediators|July 14, 1998
Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?G Sobal, J E Menzel, H Sinzinger
Biochemical Pharmacology|February 15, 2001
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycationG Sobal, E J Menzel, H Sinzinger
Atherosclerosis|January 8, 2000
Dosing of atorvastatin and increases in fibrinogen levelH Sinzinger, M Rodrigues, C D Furberg
Wiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part II)H Kritz, S R Underwood, H Sinzinger
Wiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part I)H Kritz, S R Underwood, H Sinzinger
Wiener Klinische Wochenschrift|October 6, 1997
Is it premature to recommend selenium supplementation?L Partyka, A A Aghajanian, H Sinzinger
European Journal of Nuclear Medicine|January 1, 1986
Autologous platelet labelling using "Monovette" vials is not septicH Sinzinger, E Strobl-Jäger, R Höfer
Die Medizinische Welt|July 14, 1978
[Thrombus organization and atherosclerosis]W Feigl, H Sinzinger, H G Kern
Life Sciences|March 28, 2003
Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidationG Sobal, H Sinzinger, E J Menzel
Pageof 68

Showing results (221-230 of 672) with videos related to

Sort By:
Pageof 68
Angiology|February 1, 1986
Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular diseaseH Sinzinger, P Fitscha, B A Peskar
Prostaglandins & Other Lipid Mediators|July 14, 1998
Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?G Sobal, J E Menzel, H Sinzinger
Biochemical Pharmacology|February 15, 2001
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycationG Sobal, E J Menzel, H Sinzinger
Atherosclerosis|January 8, 2000
Dosing of atorvastatin and increases in fibrinogen levelH Sinzinger, M Rodrigues, C D Furberg
Wiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part II)H Kritz, S R Underwood, H Sinzinger
Wiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part I)H Kritz, S R Underwood, H Sinzinger
Wiener Klinische Wochenschrift|October 6, 1997
Is it premature to recommend selenium supplementation?L Partyka, A A Aghajanian, H Sinzinger
European Journal of Nuclear Medicine|January 1, 1986
Autologous platelet labelling using "Monovette" vials is not septicH Sinzinger, E Strobl-Jäger, R Höfer
Die Medizinische Welt|July 14, 1978
[Thrombus organization and atherosclerosis]W Feigl, H Sinzinger, H G Kern
Life Sciences|March 28, 2003
Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidationG Sobal, H Sinzinger, E J Menzel
Pageof 68